Hungary

4iG and Digi Communications NV’s Romanian subsidiary have entered into a term sheet with regards to a potential acquisition by 4iG of DIGI Group’s Hungarian operations

(PRESS RELEASE) BUDAPEST, Hungary, 29-Mar-2021 — /EuropaWire/ — Digi Communications NV (The Company) would like to inform its investors and…

5 years ago

Digi Communications N.V. announces Share transaction made by an executive director of the Company with class B shares

(PRESS RELEASE) BUCHAREST, Romania, 17-Mar-2021 — /EuropaWire/ — The Company would like to inform the market and its investors that,…

5 years ago

Digi Communications N.V.: Announces an Amendment to the Financial Calendar for 2021

(PRESS RELEASE) BUCHAREST, Romania, 10-Mar-2021 — /EuropaWire/ — DIGI COMMUNICATIONS N.V. would like to inform its investors and the market…

5 years ago

DHL facilitates the transport of the largest order of rolling stock in the history of Hungary

DHL will manage the end-to-end transport of the coaches, each weighing 48 tons and measuring 24.5 metres in length. DHL…

5 years ago

Digi Communications NV announces the release of the 2020 Preliminary Financial Results

(PRESS RELEASE) BUCHAREST, Romania, 23-Feb-2021 — /EuropaWire/ — Digi Communications N.V. ("Digi" or the "Company") announces that the 2020 Preliminary…

5 years ago

Digi Communications NV announces Investors Call for the 2020 Preliminary Financial Results

(PRESS RELEASE) BUCHAREST, Romania, 17-Feb-2021 — /EuropaWire/ — Digi Communications N.V. ("Digi" or the "Company") announces that on 24 February…

5 years ago

A URSAPHARM Arzneimittel e a CEBINA anunciam uma parceria com vista a reaproveitar o anti-histamínico azelastina para combater a COVID-19

(PRESS RELEASE) SAARBRÜCKEN / VIENA, 17-Feb-2021 — /EuropaWire/ — Na luta contra o vírus SARS-CoV-2, um grande número de empresas…

5 years ago

URSAPHARM Arzneimittel et CEBINA annoncent un partenariat pour reconvertir l’antihistaminique azélastine afin de lutter contre la COVID-19

(PRESS RELEASE) SARREBRUCK / VIENNE, 17-Feb-2021 — /EuropaWire/ — Dans la lutte contre le virus SRAS-CoV-2, un grand nombre d'entreprises…

5 years ago

URSAPHARM Arzneimittel y CEBINA anuncian una colaboración para readaptar el antihistamínico azelastine para combatir la COVID-19

(PRESS RELEASE) SAARBRÜCKEN / VIENA, 17-Feb-2021 — /EuropaWire/ — En la lucha contra el virus SARS-CoV-2, una gran cantidad de…

5 years ago

URSAPHARM Arzneimittel and CEBINA announce partnership to repurpose the antihistamine azelastine to combat COVID-19

(PRESS RELEASE) SAARBRÜCKEN / VIENNA, 17-Feb-2021 — /EuropaWire/ — In the fight against the SARS-CoV-2 virus, a large number of…

5 years ago
Show more Posts
Show previous Posts